RECURRENT GLIOSARCOMA
Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink returning brain tumors
Disease control Recruiting nowThis early-phase trial tests whether combining two drugs, atezolizumab and cabozantinib, can safely shrink tumors in adults with glioblastoma that has returned after standard treatment. The study enrolls about 6 participants and focuses on tumor response and side effects. The goa…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Cold virus engineered to attack brain tumors shows promise in early trial
Disease control Recruiting nowThis early-phase trial tests a new approach for people with recurrent high-grade glioma, a fast-growing brain cancer. Researchers use stem cells to carry a modified cold virus directly to the tumor via an artery, where the virus is designed to infect and kill cancer cells. The ma…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug combo takes on deadly brain tumor
Disease control Recruiting nowThis study tests two immunotherapy drugs, efineptakin alfa and pembrolizumab, in people whose glioblastoma has returned after standard treatment. The goal is to see if this combination can help the immune system fight the tumor and improve survival. About 54 adults with recurrent…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Genetically modified immune cells take on recurrent brain tumors
Disease control Recruiting nowThis early-phase trial tests a new treatment for glioblastoma, a serious brain cancer that has returned after standard therapy. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, modified to resist the tumor's defenses. The main goals are t…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New hope for aggressive brain tumors: drug combo shows promise before surgery
Disease control Recruiting nowThis study tests two drugs, GI-102 and pembrolizumab, given before surgery to people whose aggressive brain cancer (glioblastoma) has returned. The goal is to see if these drugs can shrink the tumor and help the immune system fight the cancer. About 36 adults will take part, and …
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC